vzphotos Since I last wrote about the pharmaceuticals company AbbVie Inc. (NYSE:ABBV) in March, its stock market performance has been underwhelming, with a 3% price decline. This isn't an entirely surprising short-term movement. The stock was trading at higher multiples compared with its five-year average levels three months ago. The stock's price performance was also ahead of that of the S&P 500 Health Care Index, indicating the possibility for comparative attractiveness of other stocks in the sector. Inve ...